The Peptide Guide

All muscle and recovery peptides

Tirzepatide

AppetiteWeight

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied extensively for glycemic control, appetite signaling, and weight management.

What does it do?

Lowers blood sugar and improves insulin sensitivity
Reduces appetite and supports significant weight loss
Slows gastric emptying so you feel full for longer
Studied for improvements in blood pressure and lipid markers

How does it work?

Dual agonist at GIP and GLP-1 receptors
Slows gastric emptying and enhances insulin secretion
Reduces appetite through central and peripheral signaling
Improves glycemic control and supports weight management

How it's typically administered

Subcutaneous injectiononce weekly, prescription only
Pre-filled penstandard clinical delivery format
Topical serum or creamnot effective systemically
Nasal sprayunreliable absorption; little research support
Oral capsulesnot bioavailable orally
Intramuscular injectionunnecessary and higher risk

How it's typically dosed

Most common dose2.5–15 mg
FrequencyOnce weekly
Cycle durationTitrated every 4 weeks

Back to anti-aging peptides

For educational purposes only. Consult a qualified healthcare provider before considering any peptide therapy.